Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 8, 2014Exhibit Offers Experiential View of BD's Robust Portfolio from Preparation to Administration
BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, is presenting its comprehensive solutions for the hospital pharmacy during the...
-
Dec 8, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that CareFusion expects to hold a special meeting on January 21, 2015 for...
-
Dec 4, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") announced today its intention to offer senior unsecured notes under a shelf registration statement on Form S-3 (File No. 333-183059) on file with...
-
Dec 1, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that the company's presentation at the 26(th) Annual Piper Jaffray Healthcare...
-
Nov 26, 2014BD Honored with Partner of the Year Award for Leading Green Power Use
FRANKLIN LAKES, N.J., November 26, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, announced today that it has received a 2014 Green Power Leadership...
-
Nov 20, 2014
Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements...
-
Nov 6, 2014Revenue increased 11 percent to $922 million
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended...
-
Nov 4, 2014-- Reports fourth quarter adjusted diluted earnings per share from continuing operations of $1.68. This represents growth of 13.0 percent on a currency-neutral basis, or 9.1 percent including the unfavorable impact of foreign currency. Reported diluted earnings per share from continuing operations for the fourth quarter were $1.53.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.202 billion for the fourth fiscal quarter ended September 30,...
-
Oct 13, 2014Transaction Advances BD’s Entry into Next Generation Sequencing Market
FRANKLIN LAKES, N.J., October 13, 2014 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a...
-
Oct 5, 2014Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions
BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to...
-
Sep 23, 2014Point-of-care CD4 analysis system tailored to meet the needs of resource-limited settings
BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the World Health Organization (WHO) has issued a...
-
Sep 4, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Morgan Stanley Global Healthcare Conference on Monday,...
-
Aug 8, 2014Sedation Analytics Application Combines Infusion and Ventilator Data to Help Ensure Compliance with Sedation Best Practices for Ventilated Patients
SAN DIEGO, CA, Aug. 8, 2014 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the availability of a new capability on the CareFusion Respiratory Knowledge...
-
Aug 7, 2014Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.
SAN DIEGO, Aug. 7, 2014/PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2014,...
-
Aug 6, 2014The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection
FRANKLIN LAKES, N.J., August 6, 2014 – BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the retail pharmacy...
-
Aug 4, 2014Total Nucleic Acid Reagents Now Available Worldwide - Streamlined Workflow for In-House Developed Assays
BD Diagnostics, a segment of leading global medical technology company BD (Becton, Dickinson, and Company) (NYSE: BDX), announced today the availability of the Total Nucleic Acid (TNA) suite of...
-
Jul 31, 2014ChloraPrep 1 mL Applicator Provides Additional Option to Proven Portfolio of Patient Skin Preparation Products
SAN DIEGO, July 31, 2014 /PRNewswire/ – CareFusion (NYSE:CFN), a leading global medical technology company, today announced the launch of its ChloraPrep® 1 mL applicator, the newest addition to...
-
Jul 31, 2014- Announces revenues of $2.157 billion, an increase of 5.1 percent, or 4.6 percent on a foreign currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.157 billion for the third fiscal quarter ended June 30, 2014,...
-
Jul 28, 2014Assays bring an innovative solution to microbiology and molecular labs
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), (NYSE: BDX) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration for the BD ProbeTec(TM)...
-
Jul 22, 2014
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on September 30, 2014 to holders of record on...
-
Jul 10, 2014
SAN DIEGO, CA July 10, 2014 /PRNewswire/ – CareFusion Corporation (NYSE: CFN) today announced plans to release fourth quarter and fiscal 2014 results on Thursday, Aug. 7, following the close of...
-
Jun 30, 2014
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2014 earnings conference call on Thursday, July 31, at 8:00 a.m....
-
Jun 30, 2014Company Commits to Support Every Newborn Action Plan as Part of 2014 Partners' Forum
As a global medical technology company dedicated to its purpose of "Helping all people live healthy lives," BD (Becton, Dickinson and Company) (NYSE: BDX), is proud to announce its support for and...
-
Jun 25, 2014
SAN DIEGO, CA, June 25, 2014 /PRNewswire/ – The CareFusion Foundation today awarded $500,000 in grant funding to 11 U.S. nonprofit health care institutions as part of the Foundation's second...
-
Jun 18, 2014Company Commits to Support Every Newborn Action Plan as Part of 2014 Partners’ Forum
FRANKLIN LAKES, N.J., June 18, 2014 – BD (Becton, Dickinson and Company), a leading global medical technology company, has recognized eight suppliers for increasing BD’s customer satisfaction...